Notification: The Recombinant Protein Production and Characterization (RPPC) Core has undergone reorganization as of January 2026. The previous Macromolecular X-Ray Crystallography Core has been integrated into the RPPC Core and it has been renamed “Recombinant Protein Production, Characterization and Crystallography (RPPCC) Core.” The merged core provides all the same support services as previously but under a more efficient and comprehensive operational approach.
vlog the Core
The Recombinant Protein Production, Characterization, and Crystallography (RPPCC) Core is an Institutional Advanced Technology Core available to all vlog of Medicine investigators on a fee-for-service basis. The core has been reorganized by merging two existing cores - the Recombinant Protein Production and Characterization core and Macromolecular X-ray Crystallography core - to streamline protein production, biophysical characterization, and high resolution structure determination using X-ray crystallography.
The mission of the core is to provide high-quality purified protein products in sufficient quantities for various experimental applications including in vitro biochemical and biophysical analysis, macromolecular structure and as therapeutic targets for drug development projects. The major core services are the following:
- Up-front consultation on experimental design and assistance with construction of various recombinant protein expression vectors.
- Expression of recombinant proteins in three different overexpression system options including: E. Coli, baculovirus (SF9 insect cells), and mammalian cells (Expi293F).
- Purification of recombinant proteins by affinity and conventional chromatography procedures and quality control analysis of purified products. This includes investigator proteins of interest and monoclonal antibodies from existing hybridoma cell lines.
- Molecular Characterization of purified proteins by various biophysical methods.
- High resolution structure determination of macromolecules using X-ray crystallography.
Core services can be requested in .
Getting Started
If you have questions and plan to make use of the core, please email atc-protein-mab@bcm.edu. We can offer consultation in Zoom or in-person meeting.
Services
Expression of Monoclonal Antibodies (Mabs) from Existing Hybridomas (In Vitro)
Expression of Mabs from hybridoma cell lines is provided in spinner vessel cell cultures (0.5 to 3 liters) in medium containing low bovine IgG serum or in chemically defined serum-free medium. Culture supernatants from spinner vessels produce Mabs in the range of 5-50 mg/liter. Larger amounts of Mab can be produced in CL-1000 Celline flasks with the ability to generate antibody in the range of 50 -300 mg/liter.
Purification of Monoclonal Antibodies
MAbs expressed from hybridomas in culture are typically purified by Protein G/A affinity chromatography but can also be purified by custom ion exchange and size exclusion chromatography procedures. Analysis and Q/C of purified Mabs is provided by SDS-PAGE for purity, protein concentration by NanoDrop and analytic size exclusion chromatography to determine homogeneity of native molecular size. Endotoxin-free purified Mab can be provided upon request.
We are equipped with GE Healthcare’s ÄKTA Pure and ÄKTA Start chromatography systems, which allow for unattended operation and the efficient automation and optimization of purification tasks.
Choices of Chromatography Techniques
Commonly used chromatography techniques include: size exclusion chromatography (SEC, i.e., gel filtration), ion exchange chromatography (IEX), hydrophobic interaction chromatography (HIC), and affinity chromatography.
Affinity chromatograph is usually combined with specific affinity tags (i.e., 6xHis, GST, FLAG, etc.) that are used for the first step of purification to achieve enrichment of the target fusion protein.
Ion-exchange chromatography (IEX) step is usually chosen as a second binding/elution process of purification. Depending on the pI-values and differences between target and contaminant proteins, anion-exchange or cation-exchange matrices can be used to further purify the desired protein.
Gel filtration chromatography (SEC) is usually performed as a final polishing step and can be used to increase the purity and homogeneity of the protein sample. In brief, the proteins within a sample are separated on a porous matrix according to their size. Thus, not only can contaminant proteins with different molecular weights than that of the target protein be separated, but different oligomeric forms of the target protein can also be resolved. This polishing step can be very critical, especially for structural protein studies.
Gel filtration can also provide valuable information for the analysis of protein-protein interactions and can be informative about the association between one or more proteins or nucleic acids, under diverse conditions.
Prepacked Columns
We carry GE Healthcare’s prepacked affinity columns (i.e., HisTrap, GSTrap), desalting columns, and all sizes of SEC columns (from analytic scale Superdex increase to production grade Superdex). We also have hydrophobic interaction columns for procedures such as the removal of endotoxin and nuclease contaminants.
Overexpression of recombinant proteins in any of three systems
E. coli
We provide consultation for all projects and can assist with the design, construction, and expression testing of vectors featuring various affinity tags (i.e., His, GST, FLAG) and/or fusion partners (i.e., TRX, MBP, EGFP) in order to maximize the expression level of the target protein in E. coli.
Depending on the nature of the heterologous target protein, we provide and utilize a number of different E. coli host strains to improve expression levels and to maximize the odds of proper folding. For example, Rosetta™ cells are used for protein constructs containing a high number of rare E. coli codons, and Origami™ cells are used to encourage proper disulfide bond formation.
We maintain and utilize common proteases, such as TEV, PreScission and Sumo. If there are concerns about affinity tags or fusion partners interfering with the structure and function of the target protein, we can provide reliable methods for removing affinity tags.
In some cases, especially during overexpression in E. coli, expressed protein accumulates as insoluble inclusion bodies and several strategies can be used to improve the solubility of the expressed protein. Our core is equipped with Thermo MaxQ high performance shakers for optimization of expression temperature to maximize soluble expression.
For proteins that express insolubly, we can provide purification under denaturing condition (e.g. in high concentrations of urea). We are experienced in using DSF guiding refolding to determine suitable conditions to refolding by which to produce properly refolded protein from insoluble inclusion body preparations. We also routinely produce small peptides via insoluble expression in E. coli.
Insect Cells/Baculovirus Expression System
We construct recombinant baculoviruses with expression DNA vectors/bacmids provided by the investigator. Insect cells are co-transfected with wild type Autographa californica nuclear polyhedrosis virus DNA (AcNPV) and baculovirus transfer plasmids and isolates recombinant baculoviruses that arise by homologous recombination. Recombinant baculoviruses can also be generated by transfection of bacmid DNA using the Bac-to-Bac system. Recombinant baculovirus stocks from the transfection or co-transfection are plaque purified by an agarose overlay assay. Individual recombinant viral isolates are plucked from agarose and used to infect Sf9 insect cells. The infected Sf9 cells (for intracellular proteins) or culture supernatant (for secreted proteins) are provided to the investigator for expression screening and identification of the isolate with the highest level of expression. Screening is typically done by immunoblot assay.
We titer and amplify chosen positive recombinant baculovirus isolates. After selection of a specific recombinant viral isolate, a passage #1 seed stock is expanded to a 500ml volume and the passage #2 viral stock is titered by an agarose overlay plaque assay to determine the virus concentration in pfu/ml. Small aliquots of the passage #2 virus are placed at -70°C for long-term storage. The bulk of the amplified 500ml virus stock is stored at 4° C for use in protein production. In addition to amplifying seed viral stocks from newly generated recombinant baculoviruses, the resource also amplifies, titers and stores viral stocks from existing recombinant baculoviruses provided by investigators.
We express proteins of interest(POIs) in insect cells using recombinant baculovirus. Protein production is performed on a small scale in conventional spinner culture vessels in the range of 50-500volumes or on a large scale in oxygenated 5-liter bioreactors. The resource maintains two insect cell lines for protein production,Sf9 and High Five cells. The Sf9 cells are typically used to express intracellular proteins, while High Five is often preferable for secreted proteins. The expressed protein is provided to investigators either as a washed cell pellet (intracellular proteins) or as a culture supernatant (secreted protein) after pelleting of cells by centrifugation. The Core can also purify the protein of interest, if desired. Insect cells for protein production are typically grown in Grace's Insect Medium supplemented with 10% FBS(Sf9) or Express Five chemically defined serum free media (HighFive). If requested by an investigator, Sf9 insect cells will be adapted to a serum-free defined medium.
HEK293 Cells(Transient transfection)
We use Thermo/Invitrogen Expi293 expression system. The Expi293 Expression System is a complete solution for rapid, high-yield protein production from mammalian 293 cells. It is based on integrated components including high-density Expi293F cells in Expi293 Expression Medium and the cationic lipid-based ExpiFectamine 293 transfection reagent in combination with specialized transfection enhancers. The Expi293 Expression System features:
- Up to 1 g/L of protein; 2-to 10-fold higher protein yields than previous generation transient expression systems such as the FreeStyle 293 Expression System
- Rapid production of recombinant proteins in 5–7 days
- High density cultures of Expi293F cells that result in more expressing cells per milliliter of culture
- Native folding and mammalian post-translational modifications of expressed proteins
- Easy, robust culture and transfection protocols
- Easy to upscale to liters
We provide various protein characterization technologies and instruments.
Instruments are available in the Core to characterize proteins and other macromolecules. Interactions between compounds can be detected and analyzed using ITC. BLI OCTET can be used for high throughput binding affinities and kinetics. MALS will be available to assess a protein’s hydrodynamic size, size distribution, and aggregate population. Protein stabilities can be measured by DSF.
Currently available instruments, please .
- Octet
- AUC (Analytical Ultracentrifugation)
- ITC (Isothermal Titration Calorimetry)
- DLS (Dynamic Light Scattering)
- DSF (Differential Scanning Fluorimetry) Roche Thermal Cycler
- SEC-MALS (Size Exclusion Chromatography- Multi-Angle Light Scattering)
- Two MP mass photometer, Refeyn Ltd
- RedShiftBio MMS (Microfluidic Modulation Spectroscopy)
Macromolecular X-ray Crystallography services provide access to this advanced technology and assist researchers in determining the structure of their macromolecule of interest. In addition, we offer structural model building using AlphaFold and virtual drug screening services based on structural models and compound libraries.
Currently available instruments, please .
- Mosquito crystallization robot, sptlabtech
- Formulatrix Rock Imager II, Formulatrix
- Two MP mass photometer, Refeyn Ltd
Selected Publications Supported by the Core
2025
Pham S, Zhao B, Neetu N, Sankaran B, Patil K, Ramani S, Song Y, Estes MK, Palzkill T, Prasad BVV. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025;99(2):e0175724. doi: 10.1128/jvi.01757-24. PMID: 39873493; PMCID: PMC11852804.
2024
Jimmidi R, Monsivais D, Ta HM, Sharma KL, Bohren KM, Chamakuri S, Liao Z, Li F, Hakenjos JM, Li JY, Mishina Y, Pan H, Qin X, Robers MB, Sankaran B, Tan Z, Tang S, Vasquez YM, Wilkinson J, Young DW, Palmer SS, MacKenzie KR, Kim C, Matzuk MM. Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024;121(47) PMID: 39541346; PMCID: PMC11588046.
Judge A, Sankaran B, Hu L, Palaniappan M, Birgy A, Prasad BVV, & Palzkill T, Network of epistatic interactions in an enzyme active site revealed by large-scale deep mutational scanning, Proc. Natl. Acad. Sci. U.S.A. 2024;121 (12) e2313513121, PMCID: PC10962969.
Md Ashraf-Uz-Zaman, Teck Khiang Chua, Xin Li, Yuan Yao, Bala Krishna Moku, Chandra Bhushan Mishra, Vasanthi Avadhanula, Pedro A. Piedra, and Yongcheng Song. Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease ACS Infectious Diseases 2024; 10 (2), 715-731 PMCID: PMC 10922772.
2022
Gu T, Hao D, Woo J, Huang TW, Guo L, Lin X, Guzman AG, Tovy A, Rosas C, Jeong M, Zhou Y, Deneen B, Huang Y, Li W, Goodell MA. The disordered N-terminal domain of DNMT3A recognizes H2AK119ub and is required for postnatal development. Nat Genet. 2022 May;54(5):625-636. doi: 10.1038/s41588-022-01063-6. Epub 2022 May 9. PMID: 35534561; PMCID: PMC9295050.
2021
Versteeg L, Adhikari R, Poveda C, Villar-Mondragon MJ, Jones KM, Hotez PJ, Bottazzi ME, Tijhaar E, Pollet J. Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi. PLoS Negl Trop Dis. 2021 Sep 3;15(9):e0009689. doi: 10.1371/journal.pntd.0009689. PMID: 34478444; PMCID: PMC8415617.
Alvarado G, Salmen W, Ettayebi K, Hu L, Sankaran B, Estes MK, Venkataram Prasad BV, Crowe JE Jr. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun. 2021 Jul 4;12(1):4320. doi: 10.1038/s41467-021-24649-w. Erratum in: Nat Commun. 2021 Oct 14;12(1):6090. PMID: 34262046; PMCID: PMC8280134.
Strutzenberg TS, Zhu Y, Novick SJ, Garcia-Ordonez RD, Doebelin C, He Y, Chang MR, Kamenecka TM, Edwards DP, Griffin PR. Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement. J Mol Biol. 2021 Nov 5;433(22):167258. doi: 10.1016/j.jmb.2021.167258. Epub 2021 Sep 20. PMID: 34547329; PMCID: PMC8556364.
2020
Kumar D, Yu X, Crawford SE, Moreno R, Jakana J, Sankaran B, Anish R, Kaundal S, Hu L, Estes MK, Wang Z, Prasad BVV. 2.7 Å cryo-EM structure of rotavirus core protein VP3, a unique capping machine with a helicase activity. Sci Adv. 2020 Apr 15;6(16):eaay6410. doi: 10.1126/sciadv.aay6410. PMID: 32494598; PMCID: PMC7159914.
Yu X, Yi P, Hamilton RA, Shen H, Chen M, Foulds CE, Mancini MA, Ludtke SJ, Wang Z, O'Malley BW. Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes. Mol Cell, 2020 Sep 3;79(5):812-823. doi: 10.1016/j.molcel. 2020.06.031. Epub 2020 Jul 14. PMID: 32668201; PMCID: PMC7483370.
Bimler L, Ronzulli SL, Song AY, Johnson SK, Jones CA, Kim T, Le DT, Tompkins SM, Paust S. Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A. J Virol. 2020 Dec 2:JVI.01027-20. doi: 10.1128/JVI.01027-20. Epub ahead of print. Erratum in: J Virol. 2022 Oct 12;96(19):e0135822. PMID: 33268521; PMCID: PMC8092830.
Chen S, Jiao L, Liu X, Yang X, Liu X. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin. Mol Cell. 2020 Mar 19;77(6):1265-1278. doi: 10.1016/j.molcel. 2019.12.019. Epub 2020 Jan 17. PMID: 31959557; PMCID: PMC7571800.
Fuery A, Pursell T, Tan J, Peng R, Burbelo PD, Hayward GS, Ling PD. Lethal Hemorrhagic Disease and Clinical Illness Associated with Elephant Endotheliotropic Herpesvirus 1 Are Caused by Primary Infection: Implications for the Detection of Diagnostic Proteins. J Virol. 2020 Jan 17;94(3):e01528-19. doi: 10.1128/JVI.01528-19. PMID: 31723022; PMCID: PMC7000966.
2019
Lee ME, Dou X, Zhu Y, Phillips KJ. Refolding Proteins from Inclusion Bodies using Differential Scanning Fluorimetry Guided (DGR) Protein Refolding and MeltTraceur Web. Curr Protoc Mol Biol. 2019 Jan;125(1):e78. doi: 10.1002/cpmb.78. Epub 2018 Oct 29. PMID: 30371021.
Vossaert L, Wang Q, Salman R, McCombs AK, Patel V, Qu C, Mancini MA, Edwards DP, Malovannaya A, Liu P, Shaw CA, Levy B, Wapner RJ, Bi W, Breman AM, Van den Veyver IB, Beaudet AL. Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis. Am J Hum Genet. 2019 Dec 5;105(6):1262-1273. doi: 10.1016/j.ajhg.2019.11.004. Epub 2019 Nov 27. PMID: 31785788; PMCID: PMC6904821.